TGen's Ashion Analytics and HonorHealth Show How 'Organoids' Can Help Pinpoint the Right Therapies for Cancer Patients
June 23, 2020
June 23, 2020
PHOENIX, Arizona, June 23 -- The Translational Genomics Research Institute issued the following news release:
Precision medicine, using the power of the human genome to diagnose and treat patients, is about to get even more precise.
A new program called PATRIOT, developed by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, is using organoids -- laboratory cultures derived from samples of patient tumors -- to provide a whole new level o . . .
Precision medicine, using the power of the human genome to diagnose and treat patients, is about to get even more precise.
A new program called PATRIOT, developed by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, is using organoids -- laboratory cultures derived from samples of patient tumors -- to provide a whole new level o . . .